Sanofi (SNY) Receivables - Net (2009 - 2025)

Sanofi has disclosed Receivables - Net across 17 years of filings, most recently posting $9.8 billion for Q4 2025.

• Receivables - Net for Q4 2025 came in at $9.8 billion, up 19.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.8 billion (up 19.33% YoY), and the FY2025 annual result was $9.8 billion, up 19.33% from the prior year.
• Receivables - Net came in at $9.8 billion for Q4 2025 at Sanofi, up from $8.8 billion in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $9.8 billion in Q4 2025 to a low of $8.2 billion in Q2 2021.
• The 5-year median for Receivables - Net is $8.7 billion (2025), against an average of $8.8 billion.
• Across the five-year window, Receivables - Net retreated 9.59% in 2024 and increased 19.33% in 2025, its largest moves.
• Sanofi's Receivables - Net stood at $8.7 billion in 2021, then retreated by 0.73% to $8.6 billion in 2022, then advanced by 5.57% to $9.1 billion in 2023, then dropped by 9.59% to $8.2 billion in 2024, then rose by 19.33% to $9.8 billion in 2025.
• The last three Receivables - Net figures came in at $9.8 billion (Q4 2025), $8.8 billion (Q2 2025), and $8.2 billion (Q4 2024), per Business Quant data.